EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Anxiolysis for laceration repair in children: study protocol for an open-label multicenter adaptive trial (ALICE)

Naveen Poonai iD, Vinolia Arthur-Hayward, Samina Ali, Vikram Sabhaney, Quynh Doan, Evelyne Trottier, Jocelyn Gravel iD, Nam Anh Tran, Maala Bhatt, Mohamed Eltorki iD, Jennifer Thull-Freedman iD, Julie Leung iD und 4 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0324515 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Naveen Poonai und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Schulich School of Medicine and Dentistry, London, Ontario, Canada. Hauptthemen laut MEDLINE: Anti-Anxiety Agents, Anxiety, Dexmedetomidine, Lacerations. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academic Medical Organization of Southwestern Ontario, Clinical Trials Fund, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lacerations are the most common traumatic reason for children to visit an emergency department (ED), accounting for almost half of all procedures performed. Children experience considerable distress during laceration repair, despite routine application of local anesthetic. Pharmacologic anxiolysis may mitigate the negative practice of forcefully restraining a child, however, evidence for the most effective agent is lacking. We aim to determine the most effective anxiolytic agent for laceration repair in children.

Methods

This is a multicentre, phase III, three-arm, adaptive, randomized, open-label, trial. We will include children 2–12 years with a single laceration requiring suture repair in the ED. Participants will be randomized to receive intranasal dexmedetomidine (IND) 3 mcg/kg, intranasal midazolam (INM) 0.4 mg/kg, or inhaled 50% nitrous oxide (N 2 O). The primary outcome is the weighted mean anxiolysis score using the Observational Scale of Behavioral Distress – Revised (OSBD-R) from initial positioning to tying of the last suture. Secondary outcomes include need for additional anxiolytic, need for physical restraint, adverse events (AEs), and delayed maladaptive behaviors. The primary analysis will be conducted by intention-to-treat. Results will report posterior means, standard deviations (SDs), and 95% high density posterior credible intervals for Total Distress Score on the OSBD-R. We will rank interventions based on the probability that an intervention is superior (P best ) and the Surface Area Under the Cumulative Ranking Curve (SUCRA) to indicate relative anxiolytic efficacy. The mean difference in Total Distress Score and secondary outcomes will be estimated using Bayesian models. Ethics and dissemination Ethics approval will be obtained from institutional review boards of the participating sites. Informed consent will be obtained from guardians of all participants in addition to assent from all participants. Study data will be submitted for publication.

Trial registration

Clinicaltrials.gov NCT05383495

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Anxiety AgentsAnxietyDexmedetomidineLacerationsChildChild, PreschoolFemaleHumansMaleAdministration, IntranasalEmergency Service, HospitalMidazolamMulticenter Studies as TopicAdaptive Clinical Trials as TopicClinical Trials, Phase III as Topic

Substanzen

Anti-Anxiety AgentsDexmedetomidineMidazolam

Autor:innen und Institutionen

  • Department of Pediatrics, Schulich School of Medicine and Dentistry, London, Ontario, Canada.
  • Department of Epidemiology & Biostatistics, Schulich School of Medicine and Dentistry, London, Ontario, Canada.
  • Children's Health Research Institute, London Health Sciences Centre, London, Canada.
  • Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton.
  • Women and Children's Health Research Institute, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Canada.
  • Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: Naveen Poonai, Jocelyn Gravel, Mohamed Eltorki, Jennifer Thull-Freedman, Julie Leung, Arlene Jiang

Förderung

  • Academic Medical Organization of Southwestern Ontario
  • Clinical Trials Fund, Canadian Institutes of Health Research

Zitieren

APA

Poonai, N., Arthur-Hayward, V., Ali, S., Sabhaney, V., Doan, Q., Trottier, E., Gravel, J., Tran, N. A., Bhatt, M., Eltorki, M., Thull-Freedman, J., Leung, J., Beer, D., Jiang, A., Poolacherla, R., & Heath, A. (2025). Anxiolysis for laceration repair in children: study protocol for an open-label multicenter adaptive trial (ALICE). PLOS One. https://doi.org/10.1371/journal.pone.0324515

Vancouver

Poonai N, Arthur-Hayward V, Ali S, Sabhaney V, Doan Q, Trottier E, et al. Anxiolysis for laceration repair in children: study protocol for an open-label multicenter adaptive trial (ALICE). PLOS One. 2025. doi:10.1371/journal.pone.0324515

BibTeX
@article{Poonai2025,
  author = {Poonai, Naveen and Arthur-Hayward, Vinolia and Ali, Samina and Sabhaney, Vikram and Doan, Quynh and Trottier, Evelyne and Gravel, Jocelyn and Tran, Nam Anh and Bhatt, Maala and Eltorki, Mohamed and Thull-Freedman, Jennifer and Leung, Julie and Beer, Darcy and Jiang, Arlene and Poolacherla, Raju and Heath, Anna},
  title = {Anxiolysis for laceration repair in children: study protocol for an open-label multicenter adaptive trial (ALICE)},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0324515}
}
Kostenlos starten →